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During the 2007 equine inﬂ  uenza outbreak in Australia, 
respiratory disease in dogs in close contact with infected 
horses was noted; inﬂ   uenza (H3N8) virus infection was 
conﬁ  rmed. Nucleotide sequence of the virus from dogs was 
identical to that from horses. No evidence of dog-to-dog 
transmission or virus persistence in dogs was found.
R
espiratory disease in dogs caused by type A inﬂ  uenza 
virus was ﬁ  rst noted in racing greyhounds in Florida 
in January 2004 (1). This subtype H3N8 virus has a pre-
sumptive but unidentiﬁ  ed equine origin. The geographic 
extent of infection in racing greyhounds and in pet dogs 
suggest that this virus has become enzootic to the United 
States (1,2). 
In the United Kingdom, pneumonia in dogs and inﬂ  u-
enza (H3N8) virus have been retrospectively linked,  and 
subtype H3N8 infections have been identiﬁ  ed serologically 
in dogs likely to have been in close contact with horses 
during the 2003 outbreak of equine inﬂ  uenza (3,4). A 78-
bp segment of the hemagglutinin (HA) gene identiﬁ  ed in 
dogs with pneumonia had complete homology with local 
equine strains (3). Unlike the situation in the United States, 
no evidence of continuing circulation of an inﬂ  uenza virus 
of equine origin in the canine population has been found in 
the United Kingdom.
 In Australia, in late 2007, an outbreak of equine 
inﬂ  uenza virus (EIV) infection occurred in horses. Dur-
ing this outbreak, respiratory disease was noted in dogs 
of various ages and breeds that were kept near infected 
horses. Investigations were undertaken to exclude inﬂ  u-
enza virus infection.
The Study
The ﬁ  rst reported case was in a dog near a large sta-
ble; the dog became inappetant and lethargic and had had 
a slight nasal discharge and a persistent cough for several 
days. Over the next 2–3 weeks, dogs in or near stables with 
infected horses, including dogs whose owners were han-
dling infected horses or dogs (n = 6) that were only housed 
with infected dogs, were examined. Samples were also 
collected from dogs kept with horses at 5 other locations 
20–60 km from the ﬁ  rst case. Of the 40 dogs, examined, 10 
had clinical signs consistent with inﬂ  uenza (anorexia, leth-
argy, and, for some, a harsh cough that persisted for several 
weeks). All affected dogs recovered.
Nasal swabs and serum were collected from each of 
the 40 dogs; 23 were seropositive according to inﬂ  uenza 
type A blocking ELISA (5) and hemagglutinin inhibition 
(HI) assay (5) using A/equine/Sydney/2007 virus as anti-
gen (Table). HI titers were 16–256 (geometric mean 122). 
Results were discordant for 5 dogs: for 2, HI titer was high 
but ELISA results were negative; for 3, ELISA results were 
positive but HI titer was negative. These discrepancies may 
have been resolved had later sampling been possible. Con-
valescent-phase serum samples were collected 14–16 days 
later from 26 of the dogs; seroconversion was noted for 4 
of the 5 dogs with discordant ELISA and HI results. Test-
ing of 19 dogs 2 years later showed no change in HI titer, 
although ELISA results were negative for each. Each sero-
positive dog had been in close proximity to EIV-infected 
horses but not always in direct contact. No evidence of 
lateral transmission was found for dogs that did not have 
contact with horses.
Nasal swabs from 1 clinically healthy dog had a posi-
tive result in an inﬂ  uenza A real-time reverse transcription–
PCR assay (5) on 2 consecutive days. The dog remained 
clinically healthy and was seropositive (titer 64) on day 16 
after the ﬁ  rst positive swab was collected. Attempts to iso-
late virus from these swabs were unsuccessful.
Nucleic acid sequencing was conducted for the HA, 
neuraminidase (NA), and matrix (M) genes ampliﬁ  ed 
by PCR from the RNA puriﬁ   ed from 2 samples from 
this dog (A/canine/Sydney/6525/2007 and A/canine/
Sydney/6692/2007) and from a nasal swab from an infect-
ed horse (A/equine/Sydney/6085/2007) in the same stable 
(GenBank accession nos. GU045761–GU045769). Se-
quences were aligned with representative sequences from 
GenBank by using Clustal W (www.clustal.org/) before 
phylogenetic trees with bootstrapping were generated (n = 
1,000; random seed n = 111) with MegAlign (Lasergene; 
DNAStar, Madison, WI, USA). Complete nucleotide ho-
mology was found for each of the HA, NA, and M gene se-
quences from the 2 dogs and the sequence from the infected 
horse in the same stable (A/equine/Sydney/6085/2007).
When inﬂ  uenza subtype H3N8 sequences from hors-
es and dogs were compared with other subtype H3N8 
sequences in GenBank, the HA, NA, and M sequences 
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and A/equine/Ibaraki/1/2007, which were isolated during 
the 2007 equine inﬂ  uenza outbreak in Japan (Figure). The 
HA, NA, and M gene sequences from the dogs in Austra-
lia were positioned on separate clades of the phylogenetic 
trees, as opposed to those from subtype H3N8 viruses 
from dogs in the United States, which all grouped closely 
together (Figure).
Conclusions
Researchers in Japan have described transmission of 
EIV from 3 experimentally infected horses to 3 dogs indi-
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Table. Clinical signs and serologic findings for 40 dogs exposed to equine influenza virus, Australia, October 2007* 
Dog Breed  Age/sex Clinical  signs 
Day of sample 
collection 
PCR
Titer 
ELISA HI assay 
1st 2nd 1st 2nd 3rd† 1st 2nd 3rd†
1 Cattle dog x  6 mo/F  Cough  5 NS Neg  70 NA NA 64 NA NA
2 Whippet 6 mo/F  Cough, inappetance, lethargy, 
nasal discharge 
5 25 Neg 79 69 Neg  128 128 128
3 Rottweiler UK Cough,  lethargy  10 25 Neg  Neg  65 Neg  Neg Neg  Neg
4 Dalmation 3 y/MN  Cough, inappetance, lethargy 11 NS Neg  74 NA NA 64 NA NA
5 Kelpi x  9.5 y/FN  Cough, lethargy  12 26 Neg  66 74 NA 64 128 NA
6 Border collie  5 y/MN  Inappetance, lethargy  13 27 Neg  60 75 Neg  64 32 64
7 Cattle dog  4.5 y/M  Cough, lethargy  13 27 Neg  64 57 Neg  256 128 128
8 German 
shepherd 
9 y/M  Inappetance, lethargy  14 30 Neg  Neg  Neg  NA Neg Neg  NA
9 Jack Russell  9 y/MN  Cough  14 30 Neg  Neg  65 NA Neg Neg  NA
10 Lowchen  2 y/MN  Cough, inappetance, lethargy, 
nasal discharge 
26 NS Neg Neg NA Neg  Neg NA Neg
11 Cattle dog x  18 mo/F  None  10 26 Neg  77 75 NA 64 64 NA
12 Fox terrier x 
poodle
15 y/FN  None; lived with dog 4  11 NS Neg  Neg  Neg  NA Neg Neg  NA
13 Kelpie x  4 y/MN  None  12 26 Neg  64 71 Neg  128 64 128
14 German 
shepherd 
1.5 y/MN  None  12 26 Neg  71 67 Neg  128 64 64
15 Kelpie x 
labrador 
10 y/FN  None  12 26 Neg  71 80 Neg  256 32 Neg
16 Cattle x kelpie  3 y/MN  None  12 27 Neg  64 61 Neg  128 32 64
17 Unknown UK None  12 27 Neg  66 66 Neg  256 64 32
18 Border collie  1 y/M  None  12 27 Neg  78 59 Neg  128 64 128
19 Jack Russell x  2.5 y/MN  None  12 26 Neg  49 71 NA 32 16 NA
20 Greyhound 18  mo/F  None  12 26 Neg  Neg  Neg  NA 256 128 NA
21 Greyhound  2 y. M  None  12 26 Neg  Neg  55 NA Neg Neg  NA
22 Greyhound 5  y/M  None  12 25 Neg  Neg  Neg  NA Neg Neg  NA
23 Greyhound 18  mo/F  None  12 25 Neg  Neg  Neg  NA Neg Neg  NA
24 Greyhound 18  m/F  None  12 25 Neg  Neg  Neg  NA Neg Neg  NA
25 Cattle x kelpie  4 y/FN  None  12 26 Neg  51 73 Neg  128 64 64
26 Poodle 5 mo/M  None, lived with dog 7  13 27 Neg  Neg  Neg  Neg  8 Neg  Neg
27 Jack Russell  5 y/F  None, lived with dog 5  13 27 Neg  Neg  Neg  NA Neg Neg  NA
28 Cattle x 
hunterway 
4.5 y/M  None  14 30 Pos Neg  50 NA Neg 64 NA
29 Border collie  4 y/FN  None 15 NS Neg Neg NA NA Neg NA  NA
30 Cattle 13 y/MN  None  15 NS Neg  Neg  NA NA >32 NA NA
31 Jack Russell  UK None  15 NS Neg  76 NA NA 64 NA NA
32 Rottweiler UK None  15 NS Neg  76 NA Inc 128 NA 128
33 Fox terrier  4 y/MN  None  15 NS Neg  78 NA NA 32 NA NA
34 Labrador 13  y/FN  None  15 NS Neg  51 NA NA 64 NA NA
35 x UK None 18 NS Neg  Neg  NA Neg  Neg NA  Neg
36      x  UK None  18 NS Neg  73 NA Neg  64 NA 64
37 x UK None 18 NS Neg  Neg  NA Neg  Neg NA  Neg
38 x UK None 18 NS Neg  Neg  NA NA Neg NA  NA
39 x UK None 18 NS Neg  67 NA Neg  256 NA 128
40 Poodle x  9 y/UK  None, lived with dog 10  26 NS Neg Neg NA Neg  Neg NA Neg
*HI, hemagglutination inhibition; x, cross-breed; NS, not sampled; neg, negative; NA, not applicable; pos, positive; UK, unknown; MN, male neutered; FN, 
female neutered. 
†Samples collected |2 y after second sample. Inﬂ  uenza Transmission from Horses to Dogs
vidually housed with each horse (6). Their ﬁ  ndings were 
mostly consistent with ours, but there were some differ-
ences. Both studies showed direct linkage between active 
inﬂ  uenza virus infection in dogs and horses. Because some 
naturally infected dogs were only in the vicinity of stables 
and not in direct contact with horses, we believe that EIV 
may be readily transmitted from horses to dogs in close 
proximity. The mechanism of spread remains unclear, al-
though in the United Kingdom aerosol transmission was 
believed to be a major means of spread to dogs (4). Studies 
conducted during the equine inﬂ  uenza outbreak in Australia 
indicate that the levels of virus excretion from horses not 
previously exposed to the virus can be extremely high (A.J. 
Read et al., unpub. data). Although humans readily spread 
virus from horse to horse, either directly during handling or 
by fomite transmission, human transmission of EIV to dogs 
that were not in the immediate vicinity of infected horses 
was not found. Similarly, dog-to-dog transmission was not 
found when infected dogs were transported and kept with 
other dogs in urban locations where there was no opportu-
nity for contact with horses.
Although clinical signs were not observed for any of 
the dogs in Japan, >35% of the naturally infected dogs in 
Australia exhibited clinical signs, some quite severe and 
protracted. Nevertheless, virus was rarely detected in na-
sal secretions of the dogs in Australia, and there was no 
evidence of horizontal transmission to other dogs. The lack 
of clinical signs in experimentally infected dogs may be 
because of the small numbers of dogs or because of in-
oculum attenuation after passage in embryonated chicken 
eggs. That the experimentally infected dogs in Japan also 
had lower HI titers than did naturally infected dogs may be 
relevant. 
Finally, when 19 of the dogs in Australia were tested 
2 years after infection and without opportunity for reexpo-
sure, with only 1 exception, the HI antibody titers had not 
changed. This ﬁ  nding supports the interpretation that anti-
bodies detected in dogs in the United Kingdom (3,4) had 
been acquired during the equine inﬂ  uenza outbreak several 
years earlier.
The nucleotide gene sequences encoding the 2 sur-
face proteins (HA and NA) and the M protein from the in-
fected dog in Australia matched those from the horse with 
which it had contact and did not have any of the nucleotide 
changes that have been identiﬁ  ed in viruses from dogs in 
the United States (2). Such changes may be critical to, or 
a consequence of, the adaptation of EIVs to dogs and may 
play a role in enhancing the infectivity of these viruses for 
dogs because there is no evidence of continuing circulation 
of virus in dogs in Australia.
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Figure. Phylogenetic trees of inﬂ   uenza subtype H3N8 viruses. Phylogenetic analyses conducted on A) hemagglutinin genes, B) 
neuraminidase genes, and C) matrix genes. Sequences from dogs are from the same animal on successive days. Boldface indicates 
viruses identiﬁ  ed in dogs and horses in Australia, 2007, asterisks (*) indicate viruses from horses in Japan, and daggers (†) indicate 
viruses from dogs in the United States. Bootstrap values >50 are indicated at branch nodes. Bootstrap trials = 1,000; seed = 111.Dr Kirkland is a veterinary virologist and head of the virol-
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